Latest Chindex International (CHDX) Headlines C
Post# of 2
Posted On: 03/13/2014 6:39:02 AM
Latest Chindex International (CHDX) Headlines
Chindex International Up 15.5% Since SmarTrend Uptrend Call (CHDX)
Comtex SmarTrend(R) - Wed Mar 12, 5:14PM CDT
SmarTrend identified an Uptrend for Chindex International (NASDAQ:CHDX) on December 24th, 2013 at $16.70. In approximately 3 months, Chindex International has returned 15.51% as of today's recent price of $19.29.
INVESTOR ALERT - CHINDEX INTERNATIONAL INC.: The Law Offices of Vincent Wong Investigates the Sale of CHINDEX INTERNATIONAL INC. to a Consortium
Business Wire - Tue Mar 11, 1:34PM CDT
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Chindex International Inc. (NasdaqGS:CHDX) ("Chindex") in connection with the sale of the Company to a consortium led by an affiliate of TPG, an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Robert Lipson, the CEO of Chindex.
Chindex International, Inc. to Report Fourth Quarter and Full Year of 2013 Financial Results
PR Newswire - Mon Mar 10, 7:00AM CDT
Chindex International, Inc. (NASDAQ: CHDX), an American healthcare company providing healthcare services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics, today announced that the Company plans to release financial results for the fourth quarter and full year of 2013 ended December 31, 2013 on Monday, March 17, 2014, before the market opens. Management will host a conference call at 8:00 am ET on the same day to discuss financial results.
iKang Healthcare: The Latest IPO to Watch
Douglas Young, The Motley Fool - Motley Fool - Sat Mar 08, 3:24PM CST
iKang Healthcare could find the going tough in New York with its newly announced plan for a Nasdaq IPO, at least based on the lackluster record for others from China's medical sector. iKang has become the latest in a growing list of Chinese firms...
Uptrend Call Working As Chindex International Stock Rises 15.4% (CHDX)
Comtex SmarTrend(R) - Wed Mar 05, 11:17AM CST
SmarTrend identified an Uptrend for Chindex International (NASDAQ:CHDX) on December 24th, 2013 at $16.70. In approximately 2 months, Chindex International has returned 15.39% as of today's recent price of $19.27.
CHINDEX INTERNATIONAL SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Notifies Chindex International (CHDX) Investors of Claims Against Company Directors Over the Proposed Sale of the Company to TPG and Fosun Pharma -- CHDX
GlobeNewswire - Fri Feb 28, 6:35PM CST
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is examining claims against the Board of Directors of Chindex International, Inc. ("Chindex" or the "Company") (Nasdaq:CHDX) for potential breaches of fiduciary duties in connection with the sale of the Company to TPG-led group for approximately $369 million. The Company's stockholders will only receive $19.50 for each share of Chindex common stock they own. A complaint was filed in the Circuit Court of Maryland.
INVESTOR ALERT: LEVI & KORSINSKY, LLP Notifies Investors of CHINDEX INTERNATIONAL INC. of Class Action Against Its Board of Directors in Connection With the Sale of the Company to a Consortium -- CHDX
GlobeNewswire - Wed Feb 26, 9:58AM CST
Levi & Korsinsky notifies investors of Chindex International Inc. ("Chindex" or "the Company") (Nasdaq:CHDX) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to a consortium led by an affiliate of TPG, an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Roberta Lipson, the CEO of Chindex. A complaint was filed in Maryland state court.
CHINDEX INTERNATIONAL, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
PR Newswire - Mon Feb 24, 1:23PM CST
Rigrodsky & Long, P.A.:
INVESTOR ALERT - CHINDEX INTERNATIONAL INC.: The Law Offices of Vincent Wong Investigates the Sale of CHINDEX INTERNATIONAL INC. to a Consortium -- CHDX
PR Newswire - Mon Feb 24, 10:12AM CST
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Chindex International Inc. (NasdaqGS: CHDX) ("Chindex") in connection with the sale of the Company to a consortium led by an affiliate of TPG, an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Robert Lipson, the CEO of Chindex.
The Shuman Law Firm Investigates Chindex International Inc.
Business Wire - Fri Feb 21, 8:00PM CST
The Shuman Law Firm announces that it is investigating potential claims against certain officers and directors of Chindex International Inc. ("Chindex" or the "Company") (Nasdaq: CHDX).
CHINDEX INTERNATIONAL SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Chindex International Over the Proposed Sale of the Company to TPG and Fosun Pharma
PR Newswire - Fri Feb 21, 6:25PM CST
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Chindex International, Inc. ("Chindex" or the "Company") (Nasdaq: CHDX) for potential breaches of fiduciary duties in connection with the sale of the Company to TPG-led group for approximately $369 million. The Company's stockholders will only receive $19.50 for each share of Chindex common stock they own.
SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Files a Class Action Lawsuit Against Chindex International, Inc. - CHDX
PR Newswire - Fri Feb 21, 12:27PM CST
Law office of Brodsky & Smith, LLC announces that it has commenced in Circuit Court for Montgomery County Maryland a class action lawsuit against the Board of Directors of Chindex International, Inc. ("Chindex" or the "Company") (Nasdaq -CHDX-News) relating to the proposed acquisition by a buyer consortium including the Company CEO. ("Consortium").
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of CHINDEX INTERNATIONAL INC. and Its Board of Directors In Connection With the Sale of the Company to a Consortium -- CHDX
PR Newswire - Wed Feb 19, 7:42PM CST
Levi & Korsinsky commenced an investigation the Board of Directors of Chindex International Inc. ("Chindex" or "the Company") (NasdaqGS: CHDX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to a consortium led by an affiliate of TPG, an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Roberta Lipson, the CEO of Chindex.
Lifshitz & Miller Law Firm Announces Investigation of Cadence Pharmaceuticals, Inc., Chindex International, Inc., LCA-Vision, Inc., North Valley Bancorp and Texas Industries, Inc.
PR Newswire - Wed Feb 19, 2:48PM CST
Cadence Pharmaceuticals, Inc.
Maryland-Based Law Firm Brower Piven Announces Investigation of Chindex International, Inc. Proposed Buyout
Business Wire - Wed Feb 19, 12:02PM CST
The securities litigation firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Chindex International, Inc. ("Chindex" or the "Company") (NASDAQ: CHDX) and other violations of state law by the board of directors of Chindex relating to the proposed buyout of the Company by an affiliate of private equity firm TPG, an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and Chindex Chief Executive Officer, Roberta Lipson. The firm's investigation seeks to determine, among other things, whether the board of directors of Chindex breached their fiduciary duties by failing to maximize shareholder value.
INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CHINDEX INTERNATIONAL INC. and Its Board of Directors In Connection With the Sale of the Company to a Consortium
Business Wire - Wed Feb 19, 12:02PM CST
Levi & Korsinsky commenced an investigation the Board of Directors of Chindex International Inc. ("Chindex" or "the Company") (NasdaqGS:CHDX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to a consortium led by an affiliate of TPG, an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Roberta Lipson, the CEO of Chindex.
Ryan & Maniskas, LLP Announces Investigation of Chindex International Inc.
PR Newswire - Wed Feb 19, 9:56AM CST
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Chindex International Inc. ("Chindex" or the "Company") (NASDAQ: CHDX) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to TPG, an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Chindex Chief Executive Officer, Roberta Lipson, in a transaction valued at approximately $369 million.
Shares of CHDX Up 16.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Feb 19, 9:24AM CST
SmarTrend identified an Uptrend for Chindex International (NASDAQ:CHDX) on December 24th, 2013 at $16.70. In approximately 2 months, Chindex International has returned 15.99% as of today's recent price of $19.37.
Chindex International Up 15.5% Since SmarTrend Uptrend Call (CHDX)
Comtex SmarTrend(R) - Wed Mar 12, 5:14PM CDT
SmarTrend identified an Uptrend for Chindex International (NASDAQ:CHDX) on December 24th, 2013 at $16.70. In approximately 3 months, Chindex International has returned 15.51% as of today's recent price of $19.29.
INVESTOR ALERT - CHINDEX INTERNATIONAL INC.: The Law Offices of Vincent Wong Investigates the Sale of CHINDEX INTERNATIONAL INC. to a Consortium
Business Wire - Tue Mar 11, 1:34PM CDT
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Chindex International Inc. (NasdaqGS:CHDX) ("Chindex") in connection with the sale of the Company to a consortium led by an affiliate of TPG, an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Robert Lipson, the CEO of Chindex.
Chindex International, Inc. to Report Fourth Quarter and Full Year of 2013 Financial Results
PR Newswire - Mon Mar 10, 7:00AM CDT
Chindex International, Inc. (NASDAQ: CHDX), an American healthcare company providing healthcare services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics, today announced that the Company plans to release financial results for the fourth quarter and full year of 2013 ended December 31, 2013 on Monday, March 17, 2014, before the market opens. Management will host a conference call at 8:00 am ET on the same day to discuss financial results.
iKang Healthcare: The Latest IPO to Watch
Douglas Young, The Motley Fool - Motley Fool - Sat Mar 08, 3:24PM CST
iKang Healthcare could find the going tough in New York with its newly announced plan for a Nasdaq IPO, at least based on the lackluster record for others from China's medical sector. iKang has become the latest in a growing list of Chinese firms...
Uptrend Call Working As Chindex International Stock Rises 15.4% (CHDX)
Comtex SmarTrend(R) - Wed Mar 05, 11:17AM CST
SmarTrend identified an Uptrend for Chindex International (NASDAQ:CHDX) on December 24th, 2013 at $16.70. In approximately 2 months, Chindex International has returned 15.39% as of today's recent price of $19.27.
CHINDEX INTERNATIONAL SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Notifies Chindex International (CHDX) Investors of Claims Against Company Directors Over the Proposed Sale of the Company to TPG and Fosun Pharma -- CHDX
GlobeNewswire - Fri Feb 28, 6:35PM CST
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is examining claims against the Board of Directors of Chindex International, Inc. ("Chindex" or the "Company") (Nasdaq:CHDX) for potential breaches of fiduciary duties in connection with the sale of the Company to TPG-led group for approximately $369 million. The Company's stockholders will only receive $19.50 for each share of Chindex common stock they own. A complaint was filed in the Circuit Court of Maryland.
INVESTOR ALERT: LEVI & KORSINSKY, LLP Notifies Investors of CHINDEX INTERNATIONAL INC. of Class Action Against Its Board of Directors in Connection With the Sale of the Company to a Consortium -- CHDX
GlobeNewswire - Wed Feb 26, 9:58AM CST
Levi & Korsinsky notifies investors of Chindex International Inc. ("Chindex" or "the Company") (Nasdaq:CHDX) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to a consortium led by an affiliate of TPG, an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Roberta Lipson, the CEO of Chindex. A complaint was filed in Maryland state court.
CHINDEX INTERNATIONAL, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
PR Newswire - Mon Feb 24, 1:23PM CST
Rigrodsky & Long, P.A.:
INVESTOR ALERT - CHINDEX INTERNATIONAL INC.: The Law Offices of Vincent Wong Investigates the Sale of CHINDEX INTERNATIONAL INC. to a Consortium -- CHDX
PR Newswire - Mon Feb 24, 10:12AM CST
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Chindex International Inc. (NasdaqGS: CHDX) ("Chindex") in connection with the sale of the Company to a consortium led by an affiliate of TPG, an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Robert Lipson, the CEO of Chindex.
The Shuman Law Firm Investigates Chindex International Inc.
Business Wire - Fri Feb 21, 8:00PM CST
The Shuman Law Firm announces that it is investigating potential claims against certain officers and directors of Chindex International Inc. ("Chindex" or the "Company") (Nasdaq: CHDX).
CHINDEX INTERNATIONAL SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Chindex International Over the Proposed Sale of the Company to TPG and Fosun Pharma
PR Newswire - Fri Feb 21, 6:25PM CST
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Chindex International, Inc. ("Chindex" or the "Company") (Nasdaq: CHDX) for potential breaches of fiduciary duties in connection with the sale of the Company to TPG-led group for approximately $369 million. The Company's stockholders will only receive $19.50 for each share of Chindex common stock they own.
SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Files a Class Action Lawsuit Against Chindex International, Inc. - CHDX
PR Newswire - Fri Feb 21, 12:27PM CST
Law office of Brodsky & Smith, LLC announces that it has commenced in Circuit Court for Montgomery County Maryland a class action lawsuit against the Board of Directors of Chindex International, Inc. ("Chindex" or the "Company") (Nasdaq -CHDX-News) relating to the proposed acquisition by a buyer consortium including the Company CEO. ("Consortium").
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of CHINDEX INTERNATIONAL INC. and Its Board of Directors In Connection With the Sale of the Company to a Consortium -- CHDX
PR Newswire - Wed Feb 19, 7:42PM CST
Levi & Korsinsky commenced an investigation the Board of Directors of Chindex International Inc. ("Chindex" or "the Company") (NasdaqGS: CHDX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to a consortium led by an affiliate of TPG, an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Roberta Lipson, the CEO of Chindex.
Lifshitz & Miller Law Firm Announces Investigation of Cadence Pharmaceuticals, Inc., Chindex International, Inc., LCA-Vision, Inc., North Valley Bancorp and Texas Industries, Inc.
PR Newswire - Wed Feb 19, 2:48PM CST
Cadence Pharmaceuticals, Inc.
Maryland-Based Law Firm Brower Piven Announces Investigation of Chindex International, Inc. Proposed Buyout
Business Wire - Wed Feb 19, 12:02PM CST
The securities litigation firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Chindex International, Inc. ("Chindex" or the "Company") (NASDAQ: CHDX) and other violations of state law by the board of directors of Chindex relating to the proposed buyout of the Company by an affiliate of private equity firm TPG, an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and Chindex Chief Executive Officer, Roberta Lipson. The firm's investigation seeks to determine, among other things, whether the board of directors of Chindex breached their fiduciary duties by failing to maximize shareholder value.
INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CHINDEX INTERNATIONAL INC. and Its Board of Directors In Connection With the Sale of the Company to a Consortium
Business Wire - Wed Feb 19, 12:02PM CST
Levi & Korsinsky commenced an investigation the Board of Directors of Chindex International Inc. ("Chindex" or "the Company") (NasdaqGS:CHDX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to a consortium led by an affiliate of TPG, an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Roberta Lipson, the CEO of Chindex.
Ryan & Maniskas, LLP Announces Investigation of Chindex International Inc.
PR Newswire - Wed Feb 19, 9:56AM CST
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Chindex International Inc. ("Chindex" or the "Company") (NASDAQ: CHDX) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to TPG, an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Chindex Chief Executive Officer, Roberta Lipson, in a transaction valued at approximately $369 million.
Shares of CHDX Up 16.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Feb 19, 9:24AM CST
SmarTrend identified an Uptrend for Chindex International (NASDAQ:CHDX) on December 24th, 2013 at $16.70. In approximately 2 months, Chindex International has returned 15.99% as of today's recent price of $19.37.
(0)
(0)Chindex International (CHDX) Stock Research Links
Scroll down for more posts ▼